Garrett Applauds FDA for Accelerating Approval of Duchenne Treatment


Date: Sept. 21, 2016
Location: Washington, DC
Issues: Drugs

Rep. Scott Garrett (NJ-05) issued the following statement after the Food and Drug Administration (FDA) this week announced the accelerated approval for a new treatment for Duchenne muscular dystrophy:

"I was encouraged by the FDA's announcement this week that a new treatment for Duchenne Muscular Dystrophy received accelerated approval after I recently called on them to do so. This is an important step that gives children facing this devastating and rare disease access to a promising treatment. This issue is important to me, and I will continue to make sure the FDA is not holding up potentially life-saving treatments for our kids."